Literature DB >> 24642519

Treatment of multidrug-resistant and extensively drug-resistant tuberculosis in adolescent patients.

Magda Rodrigues1, Maria Brito, Miguel Villar, Paula Correia.   

Abstract

The authors describe 2 pediatric patients with drug-resistant tuberculosis in whom new diagnostic and therapeutic approaches were crucial to good clinical evolution. Although there was good clinical outcome, important side effects with linezolid and amikacin occurred, namely medullary hypoplasia and neurosensorial hypoacusia, respectively. A multidisciplinary approach with close follow up was of major importance in managing these patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24642519     DOI: 10.1097/INF.0000000000000341

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  2 in total

Review 1.  Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis.

Authors:  James A Seddon; H Simon Schaaf
Journal:  Pneumonia (Nathan)       Date:  2016-11-24

2.  Effect of linezolid on serum PCT, ESR, and CRP in patients with pulmonary tuberculosis and pneumonia.

Authors:  Rui-Dong Ding; Hong-Jun Zhang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.